Jump to content

Definition:Overlap assumption

From Insurer Brain

🔀 Overlap assumption — also called the positivity or common support condition — requires that for every combination of observed characteristics in a study population, there is a nonzero probability of receiving each treatment level. Within insurance causal inference applications, the assumption ensures that treated and untreated groups share comparable profiles so that meaningful comparisons can be drawn. If a carrier wants to estimate the causal effect of offering a telematics discount on claims frequency, the overlap assumption demands that across every stratum of age, vehicle type, geography, and driving history, some policyholders did and some did not enroll — otherwise, the effect for certain subgroups is fundamentally unidentifiable.

⚙️ Violations typically surface when treatment assignment is nearly deterministic for certain covariate profiles. In insurance, this can happen when underwriting rules make a product feature effectively mandatory or unavailable for specific risk classes. For example, if all commercial trucking policies above a certain fleet size are automatically placed into a captive arrangement, there is no overlap for large fleets — analysts cannot compare captive and non-captive outcomes at that scale without extrapolating beyond the data. Diagnostics include inspecting propensity score distributions across treatment groups and trimming or reweighting observations in regions of near-zero overlap. Analysts working with predictive models in pricing or loss prevention program evaluation routinely check overlap as a prerequisite before applying matching, weighting, or regression-based causal estimators.

📌 Ignoring overlap violations can produce wildly unstable estimates — a few observations with extreme propensity scores can dominate weighted analyses, yielding conclusions that appear precise but rest on implausible extrapolations. For insurers operating across diverse portfolios, this is more than a statistical nuisance: flawed causal estimates can misguide product design, distort rate filings, or lead reinsurers to misprice treaties. Practically, ensuring overlap may require restricting analysis to subpopulations where sufficient variation in treatment exists — a discipline that forces analytical teams to be transparent about the scope of their conclusions. In regulatory contexts, demonstrating overlap strengthens the evidentiary foundation when carriers present rating factor impact studies to supervisors under frameworks such as Solvency II or the NAIC guidelines.

Related concepts: